Antiimmunoglobulins of rheumatoid factor (RF) type in prediction of melanoma patients.
It was found out the titer of antiimmunoglobulins of the rheumatoid factor (RF) type in the sera of melanoma patients can be used in prediction of the development of the patients' status. High titers of antiimmunoglobulins of the RF type, determined by the latex-fixation test (LFT), indicate an unfavorable prognosis in patients with clinical manifestation of uncontrollable recurrence appearing from 1.5 to 2 years after occurrence of the LFT titer.
D000917:Antibody Formation; D001323:Autoantibodies / Q000032:analysis*; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology*; D008545:Melanoma / Q000276:immunology*; D011379:Prognosis; D012217:Rheumatoid Factor / Q000276:immunology*
D001323:Autoantibodies; D007136:Immunoglobulins; D012217:Rheumatoid Factor